CytoReason vs MDClone

CytoReason vs MDClone, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and MDClone on 62/100.

CytoReason logo
CytoReasonDevelops a computational model of the human body for drug discovery and development.
Try CytoReason
MDClone logo
MDCloneSelf-service data analytics platform for healthcare ecosystems, enabling exploration and discovery.
Try MDClone

Where each one leads

CytoReason

  • our overall score: 68/100 against 62/100
  • headcount growth: +13.7% against -5.6%
  • LinkedIn following: 12,830 against 6,023

MDClone

  • agent readiness: 45/100 against 21/100
  • domain rating: 50/100 against 40/100

At a glance

MeasureCytoReasonMDClone
What it isDevelops a computational model of the human body for drug discovery and development.Self-service data analytics platform for healthcare ecosystems, enabling exploration and discovery.
CategoryHealthcare, Drug Discovery, Clinical Development, BiomarkersHealthcare, Synthetic Data, HealthTech, MedTech
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded20162015
HeadquartersTel Aviv, IsraelBe'er Sheva, Israel
StatusActiveActive

Size, funding and growth

MeasureCytoReasonMDClone
Employees116115
Headcount growthLast 12 months+13.7%-5.6%
Total funding$128M$104M
Latest roundSeries BSeries C
LinkedIn followers12,8306,023

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCytoReasonMDClone
StartupHub scoreOur 0-100 rating68/10062/100
Traction60/10060/100
Team70/10070/100
Search visibility30/10036/100
Quality78/10065/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)D (45/100)
Domain ratingLink authority, 0-10040/10050/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCytoReasonMDClone
CDNNot detectedCloudflare
CMSNot detectedWordPress
FrameworksNot detectedJquery
AnalyticsSegmentGoogle Tag Manager
Support stackNot detectedHubSpot

CytoReason vs MDClone: common questions

Which is better, CytoReason or MDClone?

On our 0-100 score CytoReason rates higher (68/100 against 62/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do CytoReason and MDClone compare on the numbers?

CytoReason leads on our overall score (68/100 against 62/100), headcount growth (+13.7% against -5.6%), LinkedIn following (12,830 against 6,023). MDClone leads on agent readiness (45/100 against 21/100), domain rating (50/100 against 40/100).

Read the full CytoReason review and pricing or the MDClone review and pricing. You can also browse other CytoReason alternatives we track.